Am J Transplant, Volume 17, Suppl 3 Archives - Page 134 of 181 - ATC Abstracts

2017 American Transplant Congress
Novel Insights into the Synergism of CD40 Autoantibodies and suPAR in Kidney Transplant Patients with FSGS Recurrence.
T. Sigdel, C. Wei, F. Vencenti, J. Reiser, M. Sarwal.
University of California San Francisco, San Francisco
Background: FSGS is a histopathological lesion that has a 40-80% risk of recurrence o in the transplanted (tx) kidney, with increased risk of graft loss.…
2017 American Transplant Congress
A Nationwide Global Strategy for Kidney Transplantation with Controlled Cardiac Death Donor (cDCD) Has Improved Global Results. Spanish Multicentre SENTRA-GEODAS Group.
J. Portoles,^1,2 M. Perez-Saez,^2,3 D. Janeiro,^1,2 E. Melilli,² N. Maruri Kareaga,² E. de Souza,² F. Llamas,² J. Espi,² P. Martin Moreno,² D. Navarro,² A. Sancho-Calabuig,² M. Rodriguez-Ferrero,² D. Hernandez,² J. Pascual.^2,3
¹Nephrology, Hospital Puerta de Hierro, Majadahonda, Spain; ²GEODAS-SENTRA Public Health Research Net RedinRen16/009/009 RETYC ISCIII, Madrid, Spain; ³Nephrology, Hospital del Mar, Barcelona, Spain
Background: Controlled donation after cardiac death (cDCD) programs are running in US for years and some European countries has recently started on it. National transplant…
2017 American Transplant Congress
Association of Dialysis Facility Neighborhood Socioeconomic Status with Barriers to Kidney Transplant.
K. Ross,¹ M. Basu,² C. Escoffery,³ J. Gander,² S. Mohan,⁴ S. Pastan,² L. Plantinga,¹ K. Smith,² R. Patzer.^1,2
¹Department of Epidemiology, Rollins School of Public Health, Atlanta; ²Department of Surgery, Emory University School of Medicine, Atlanta; ³Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Atlanta; ⁴Department of Medicine, Columbia University Medical Center, New York
Introduction: Dialysis facilities in neighborhoods with low socioeconomic status (SES) have lower facility-level transplantation rates. We estimated the association between barriers to transplantation and facility-area…
2017 American Transplant Congress
Engaging Clinicians and Patients Regarding Frailty Assessment in Kidney Transplant Candidates.
S. Rasmussen, J. Konel, H. Ying, C. Haugen, E. King, S. DiBrito, D. Segev, M. McAdams DeMarco.
JHU, Baltimore
Background: The Fried frailty phenotype, a measure of physiologic reserve, is associated with poor kidney transplant (KT) outcomes. However, it was developed in community-dwelling older…
2017 American Transplant Congress
Burden of Early Hospitalization Among Liver Transplant Recipients.
P. Sharma,¹ N. Goodrich,³ D. Schaubel,² A. Smith,³ R. Merion.^3,4
¹Gastroenterology, University of Michigan, Ann Arbor, MI; ²Biostatistics, University of Michigan, Ann Arbor, MI; ³Arbor Research Collaborative for Health, Ann Arbor, MI; ⁴Surgery, University of Michigan, Ann Arbor, MI
Hospitalization is known to occur frequently in the first six months following liver transplantation (LT). We examined the burden of hospitalization within 6 months of…
2017 American Transplant Congress
Malignancy in Patients Undergoing Simultaneous Heart-Liver and Heart-Kidney Transplant.
A. Chin, A. Habertheuer, A. Chou, M. Acker, M. Williams, P. Atluri, C. Bermudez, P. Vallabhajosyula.
University of Pennsylvania, Philadelphia, PA
Purpose: While evidence suggests that patients undergoing simultaneous heart-liver and heart-kidney transplant may have improved immunoprotection from allograft rejection versus patients undergoing heart transplant only,…
2017 American Transplant Congress
Risk of Amiodarone and Permanent Pacemaker Placement After Heart Transplantation.
E. Kransdorf, M. Kittleson, J. Patel, T. Aintablian, R. Levine, B. Kearney, N. Musto, A. Hage, D. Geft, L. Czer, F. Esmailian, A. Trento, J. Kobashigawa.
Cedars-Sinai Heart Institute, Los Angeles
Background: Patients (pts) with end stage heart disease undergoing heart transplantation (HT) may be on amiodarone (AD) for arrhythmias. AD may persist for weeks after…
2017 American Transplant Congress
A Novel MyD88 Inhibitor Attenuates Allograft Rejection in Heterotopic Tracheal Transplantation in Mice.
M. Yang, X. Zhang, G. Chen, Z.-C. Ding, Y. Miao, Y. Yang, P. Zhou.
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technolog; Key Lab of Ministry of Education & Ministry of Health of China, Wuhan, Hubei, China
Background: Obstructive bronchiolitis (OB) characterized by chronic rejection, is the main complication after lung transplantation which limits the long-term survival of the recipients. Innate immune…
2017 American Transplant Congress
Impact of Pancreas Transplant Failure in Quality of Life in Simultaneous Kidney Pancreas Transplantation.
B. Alharbi, S. Aquil, H. Sharma, O. Ali, P. Luke, A. Sener.
Departments of Surgery and Microbiology and Immunology, Matthew Mailing Center for Translational Transplant Studies, Western University, London, London, ON, Canada
BackgroundBoth kidney and pancreas transplantation have been shown to be associated with improved quality of life (QoL). In fact, one of the most important outcomes…
2017 American Transplant Congress
Urinary Concentration Ability in Kidney Transplant Patients as Predictor for CKD.
P. Garcia-Garcia,¹ A. Jarque,¹ A. Rivero,¹ A. Rodriguez,¹ J. Gonzalez Posadas,¹ M. Macia,¹ V. Garcia Nieto,² J. Navarro.¹
¹Nephrology Service, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; ²Pediatric Nephrology Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
Urinary concentration is the result of a complex glomerulotubular mechanism, which culpits with the stimulation of aquaporins at the collector tubule, in response to vasopressin…